Literature DB >> 12161299

Combination drug therapy with vasopressin, adrenaline (epinephrine) and nitroglycerin improves vital organ blood flow in a porcine model of ventricular fibrillation.

Keith G Lurie1, Wolfgang G Voelckel, Demos N Iskos, Scott H McKnite, Todd M Zielinski, Atsushi Sugiyama, Volker Wenzel, David Benditt, Karl H Lindner.   

Abstract

There is increasing evidence that the combination of epinephrine (adrenaline) with vasopressin may be superior to either epinephrine or vasopressin alone for treatment of cardiac arrest. However, the optimal combination, and dosage of cardiovascular drugs to minimize side effects, and to improve outcome has yet to be found. We therefore evaluated whether the combination of vasopressin plus epinephrine plus nitroglycerin (EVN), would improve vital organ blood flow during cardiopulmonary resuscitation (CPR) when compared with epinephrine (EPI) alone. After 4 min of ventricular fibrillation (VF) and 4 min of standard CPR, pigs were randomized to the combination of epinephrine (45 microg/kg) plus vasopressin (0.4 U/kg) plus nitroglycerin (7.5 microg/kg; n=12), or epinephrine (40 microg/kg; n=12) alone. Cerebral and myocardial blood flow was measured with radiolabeled microspheres. Defibrillation was attempted after 19 min of VF including 15 min of CPR. Mean+/-SEM coronary perfusion pressures were significantly (P < 0.01) higher 5 min after EVN vs. EPI alone (34+/-3 vs. 24+/-3 mmHg, respectively). At the same time, mean+/-SEM left ventricular, and global cerebral blood flow was also significantly (P < 0.05) higher after EVN vs. EPI alone (0.78+/-0.11 vs. 0.48+/-0.08 ml/min/g; and 0.37+/-0.05 vs. 0.22+/-0.0 3 ml/min/g, respectively). Spontaneous circulation was restored in 11 of 12 animals in the EVN group vs. 6 of 12 swine after EPI alone (P = N.S.). In conclusion, the combination of EVN significantly improved vital organ blood flow during CPR compared with EPI alone. Addition of nitroglycerin to the combination of low dose epinephrine with vasopressin during cardiac arrest may be beneficial.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12161299     DOI: 10.1016/s0300-9572(02)00096-5

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  4 in total

Review 1.  Drug administration in animal studies of cardiac arrest does not reflect human clinical experience.

Authors:  Joshua C Reynolds; Jon C Rittenberger; James J Menegazzi
Journal:  Resuscitation       Date:  2007-03-13       Impact factor: 5.262

2.  Effect of vasopressin on hippocampal injury in a rodent model of asphyxial cardiopulmonary arrest.

Authors:  Nan Zhang; Xiu-Xian Zang; Ning Dong; Fang Liu; Shao-Kun Wang; H E Yan; DA-Hai Xu; Xiao-Liang Liu; L I Pang
Journal:  Exp Ther Med       Date:  2016-01-28       Impact factor: 2.447

Review 3.  Pharmacological Approach for Neuroprotection After Cardiac Arrest-A Narrative Review of Current Therapies and Future Neuroprotective Cocktail.

Authors:  Rishabh C Choudhary; Muhammad Shoaib; Samantha Sohnen; Daniel M Rolston; Daniel Jafari; Santiago J Miyara; Kei Hayashida; Ernesto P Molmenti; Junhwan Kim; Lance B Becker
Journal:  Front Med (Lausanne)       Date:  2021-05-18

4.  High dose nitroglycerin treatment in a patient with cardiac arrest: a case report.

Authors:  Maya Guglin; Gilbert Postler
Journal:  J Med Case Rep       Date:  2009-08-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.